30Jan

UK lateral flow rapid test manufacturer Abingdon Health confirms expansion

Following a successful 2019, Abingdon Health is expanding its York-based facility, giving the company the space and capabilities necessary to continue to drive forward rapid diagnostic testing innovation and growth.

 

Abingdon Health, which develops and manufactures lateral flow rapid diagnostic tests, saw its revenue increase by 90% in 2019, due to several new contract wins and the development of its AppDx Smartphone reader software, which was the catalyst for its recent expansion. The expansion will see the company grow their footprint by 42 per cent, including new quality-control and research and development laboratories, increased assembly space and client meeting rooms.

 

From its National Agri-Food Innovation Campus location in York, Abingdon Health will also be able to accommodate the increasing demand for customer on-site visits and expand the volume of product batches which can be manufactured at one time. 


2019 also saw Abingdon Health’s employee levels expand by 20% with this increase in personnel set to grow in 2020 and beyond.

 

Michael Hunter, Operations Director at Abingdon Health, who has led the expansion activities commented:

"We are very excited about the next phase of our business growth and this expansion will give us the ability to invest in our team and continue to meet the increasing demand for our assay and reader services.”

 

The recent growth of Abingdon Health is testament to the increasing demand for rapid testing, especially in the area of mHealth. Contact Abingdon Health for more information about lateral flow rapid diagnostics and their services.

Related

Safe, Easy UN3373 Sample Transport

The latest addition to the SpeciSafe® range, from Alpha Laboratories, is a pack to enclose two pae...

Read More >

BBI Solutions demonstrates internal antibody development capabilities while expanding their infectious disease reagent suite

BBI Solutions has released four new antibodies specific for the HIV-1 p24 capsid protein. The antibo...

Read More >

Proteome Sciences plc announce Good Clinical Laboratory Practice Accreditation

Proteome Sciences are pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) ac...

Read More >

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and colleagues from Animal Health Research Institute

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and c...

Read More >

PrimeStore® MTM novel viral transport media successfully evaluated by Public Health England for SARS-CoV-2 inactivation

Patented transport media manufactured by EKF Diagnostics can help to increase COVID-19 testing cap...

Read More >

OGT unveils reliable somatic CNV detection for CLL with new NGS panel

SureSeq™ CLL + CNV - comprehensive CLL genomic profiling from a single assay

Read More >